Back to resultsCarbamazepine Treatment of Cocaine Dependence - 1
Primary Purpose
Cocaine-Related Disorders, Substance-Related Disorders
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Carbamazepine
Sponsored by
About this trial
This is an interventional treatment trial for Cocaine-Related Disorders focused on measuring Cocaine, Substance Abuse
Eligibility Criteria
Please contact site for information.
Sites / Locations
- Medical University of South Carolina
Outcomes
Primary Outcome Measures
Severity addiction
Amount of drug use
Affective stability
Medication compliance
Secondary Outcome Measures
Full Information
NCT ID
NCT00000242
First Posted
September 20, 1999
Last Updated
April 6, 2017
Sponsor
Medical University of South Carolina
Collaborators
National Institute on Drug Abuse (NIDA)
1. Study Identification
Unique Protocol Identification Number
NCT00000242
Brief Title
Carbamazepine Treatment of Cocaine Dependence - 1
Official Title
Carbamazepine Treatment of Cocaine Dependence
Study Type
Interventional
2. Study Status
Record Verification Date
July 1996
Overall Recruitment Status
Completed
Study Start Date
October 1, 1992 (Actual)
Primary Completion Date
January 25, 1997 (Actual)
Study Completion Date
January 25, 1997 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medical University of South Carolina
Collaborators
National Institute on Drug Abuse (NIDA)
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to compare the efficacy of carbamazepine in treatment of cocaine-dependence in patients with affective disorders.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders, Substance-Related Disorders
Keywords
Cocaine, Substance Abuse
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Enrollment
0 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Carbamazepine
Primary Outcome Measure Information:
Title
Severity addiction
Title
Amount of drug use
Title
Affective stability
Title
Medication compliance
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kathleen Brady, Ph.D.
Organizational Affiliation
Medical University of South Carolina
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical University of South Carolina
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29425 742
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
7587977
Citation
Brady KT, Sonne S, Randall CL, Adinoff B, Malcolm R. Features of cocaine dependence with concurrent alcohol abuse. Drug Alcohol Depend. 1995 Jul;39(1):69-71. doi: 10.1016/0376-8716(95)01128-l.
Results Reference
background
Learn more about this trial
Carbamazepine Treatment of Cocaine Dependence - 1
We'll reach out to this number within 24 hrs